AASLD abstracts:
tony - you can brouse all the abstracts by day on the website
most of the posters on novel HCV compounds are in the monday poster session
zgen is presenting the full data set from the 1b in this poster session - all that is out is the title, nothing more
based on titles alone i found nothing hugely intriguing except for maybe an analysis of viral kinetics from inform comparing protease-soc and protease-polymerase, suggesting the latter has similar kinetics (i.e. adding polymerase inhibitor suppresses resistance to the protease similar to soc). i say it is only mildly interesting because this was an expected outcome based on preclinical models, and tells you nothing about relapse, which is the area of greatest uncertainty when talking about removing soc from future regimens
Market Data 
Markets 
AI
